Covered recipient · General Payments record
BROOKE L REYNOLDS
Eye and Vision Services Providers Optometrist
General Payments · PY2018–2024
$3,838.47
- Reported across 239 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.42 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.49 | 15 |
| GLAUKOS CORPORATION | $79.96 | 4 |
| Alcon Laboratories Inc | $78.11 | 4 |
| Oyster Point Pharma, Inc. | $53.53 | 2 |
| Tarsus Pharmaceuticals, Inc. | $31.86 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $30.42 | 2 |
| Amgen Inc. | $21.45 | 1 |
| Harrow Eye, LLC | $21.08 | 1 |
| Thea Pharma Inc. | $16.64 | 1 |
| RxSight Inc | $16.41 | 1 |
| Bausch & Lomb Americas Inc. | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.14 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940626 | CMS |
| ABBVIE INC. | $22.67 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940628 | CMS |
| ABBVIE INC. | $12.25 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940630 | CMS |
| ABBVIE INC. | $3.32 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940632 | CMS |
| ABBVIE INC. | $20.80 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940634 | CMS |
| ABBVIE INC. | $2.87 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940636 | CMS |
| ABBVIE INC. | $18.31 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940638 | CMS |
| ABBVIE INC. | $5.17 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940640 | CMS |
| ABBVIE INC. | $15.22 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940642 | CMS |
| ABBVIE INC. | $6.48 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940644 | CMS |
| ABBVIE INC. | $7.82 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940646 | CMS |
| ABBVIE INC. | $23.07 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940648 | CMS |
| ABBVIE INC. | $6.17 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940650 | CMS |
| ABBVIE INC. | $25.02 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940652 | CMS |
| ABBVIE INC. | $8.18 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105940654 | CMS |
| Alcon Vision LLC | $18.11 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110646323 | CMS |
| Alcon Vision LLC | $23.96 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110646327 | CMS |
| Alcon Vision LLC | $21.32 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110646325 | CMS |
| Alcon Vision LLC | $14.72 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110646321 | CMS |
| Amgen Inc. | $21.45 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111687145 | CMS |
| Bausch & Lomb Americas Inc. | $13.47 | 03/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140315162 | CMS |
| Glaukos Corporation | $17.19 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151995222 | CMS |
| Glaukos Corporation | $20.65 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151995226 | CMS |
| Glaukos Corporation | $18.00 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151995224 | CMS |
| Glaukos Corporation | $24.12 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151995228 | CMS |
| Harrow Eye, LLC | $21.08 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145613272 | CMS |
| Oyster Point Pharma, Inc. | $19.96 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147422519 | CMS |
| Oyster Point Pharma, Inc. | $33.57 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147428983 | CMS |
| RxSight Inc | $16.41 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144226618 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $15.76 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152132018 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $14.66 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152132020 | CMS |
| Tarsus Pharmaceuticals, Inc. | $31.86 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139127226 | CMS |
| Thea Pharma Inc. | $16.64 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074544269 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.